The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power
Enrico Franceschi(Istituto delle Scienze Neurologiche di Bologna), Anna Maria Cremonini(Institute of Neurological Sciences), Fabio Calbucci(Maria Cecilia Hospital), Claudia Mucciarini(Azienda Unita' Sanitaria Locale Di Modena), Donata Guidetti, Francesca Zanelli(Ospedale Santa Maria), Anna Pisanello, A. Valentini, Benedetta Urbini(Ospedale Sant'Anna), A. Tosoni(Istituto Oncologico Veneto), Alexandro Paccapelo(Azienda USL di Bologna), Ermanno Emiliani(University of Parma), Roberto Michelucci(Istituto delle Scienze Neurologiche di Bologna), Stefania Bartolini(Istituto delle Scienze Neurologiche di Bologna), Ermanno Giombelli(University of Parma), Fiorenzo Albani(University of Pavia), Samuele Ceruti(Clinica Luganese Moncucco), Maria Michiara, Giacomo Pavesi(University of Modena and Reggio Emilia), Claudia Biasini(Guglielmo da Saliceto Hospital), Dario de Biase(Azienda USL di Bologna), Santino Minichillo(Azienda USL di Bologna), Norina Marcello(University of Cagliari), Agostino Baruzzi(University of Pavia), Vania Ramponi(Institute of Neurological Sciences), Roberta Depenni(University of Modena and Reggio Emilia), Luigi Cavanna(University of Pavia), Francesco Fiorica(University of Verona), Michele Alessandro Cavallo(University of Ferrara), Girolamo Crisi(University of Parma), R Tamarozzi(Ospedale Sant'Anna), Enrico Sasso(University of Parma), Claudio Dazzi(Azienda Ospedaliero-Universitaria Careggi), Alba A. Brandes(Istituto delle Scienze Neurologiche di Bologna), Damiano Balestrini(Ospedale Bellaria), Antonio Fioravanti(Istituti Ospitalieri di Cremona), Alicia Tosoni(Medisch Centrum Haaglanden), R. D’Alessandro(Hôpital Cochin), Vincenzo Eusebi(University of Bologna), Luigino Tosatto(Ospedale “M. Bufalini” di Cesena), Enrico Fainardi(University of Parma), Elena Pasini
Cited by 59
Related Papers
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
|Journal of Clinical Oncology|2009|573
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature
|The Oncologist|2015|531